Drugs
-
-
Special Features
Timely and easy-to-read articles covering drug-related issues.
-
2012
- 09/18/2012
From the manufacturers’ mouth to your ears: Direct to consumer advertising - 08/08/2012
Advisory Committees: Another Set of Regulatory Eyes, Ears and Voices
By Lois Chester, Office of Communications - 07/23/2012
FDA Hits World-wide AIDS Drug Milestone - 06/12/2012
Everything you always wanted to know about approved medicines (but didn't know where to look) - 04/11/2012
Drug that treats symptoms of schizophrenia available for first time as a generic - 04/04/2012
Qualification program may facilitate drug development through novel tools - 04/02/2012
FDA approves first Avapro/Avalide generics to treat high blood pressure, kidney disease - 03/29/2012
Clarification of dosing and warning recommendations for Celexa - 03/23/2012
FDA Considers Expanding Definition of Nonprescription Drugs - 03/14/2012
Popular Prescription Drugs Hitting the Market in Generic Form - 03/08/2012
Guidance Outlines How FDA Communicates, Prioritizes Drug Safety Issues -
Cholesterol-lowering drugs get labeling changes
By Patrick E. Clarke, Office of Communications - 01/25/2012
ADHD: Not Just for Kids
By Patrick E. Clarke, Office of Communications
-
-
2011
- 11/14/2011
Frequently Asked Questions about the FDA Drug Approval Process
By the Office of Communications - 07/20/2011
An Important FDA Reminder for Parents: Do Not Give Infants Cough and Cold Products Designed for Older Children - 07/19/2011
CDER Takes Steps to End Prescription Pain Medicine Misuse, Abuse, and Addiction
By the Office of Communications - 05/05/2011
FDA Encourages Pediatric Information on Drug Labeling
By Patrick E. Clarke, Office of Communications - 04/22/2011
Don't Be Tempted to Use Expired Medicines
By Sherunda Lister, Office of Communications - 03/07/2011
SmartTots Aims to Make Anesthesia and Surgery Safer for Children Under Four
By Patrick E. Clarke, Office of Communications
-
?
Contact FDA
Toll Free
(855) 543-3784, or
(301) 796-3400
Human Drug Information
Division of Drug Information (CDER)
Office of Communications
10001 New Hampshire Avenue
Hillandale Building, 4th Floor
Silver Spring, MD 20993
-
-
